Moderna | MRNA - Gross Profit On Sales

Stock Price
41.01
Daily Change
0.14 0.34%
Monthly
14.27%
Yearly
25.80%
Q1 Forecast
42.71

Moderna reported $809M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 256.99M 13.15M Sep/2025
Agios Pharmaceuticals USD 11.2M 448K Sep/2025
Alnylam Pharmaceuticals USD 1.05B 418.14M Sep/2025
Amgen USD 6.48B 307M Sep/2025
Arrowhead Research USD 256.47M 228.7M Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
BioMarin Pharmaceutical USD 631.2M 39.27M Sep/2025
Celltrion KRW 626.11B 81.75B Sep/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 14.54B 1.5B Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Incyte USD 1.27B 130.22M Sep/2025
Ionis Pharmaceuticals USD 155M 293M Sep/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Knight Therapeutics CAD 44.83M 9.96M Jun/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Moderna USD 809M 791M Sep/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Pharma Mar EUR 33.36M 20.25M Sep/2025
Qiagen NV USD 344.8M 10.51M Sep/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Sarepta Therapeutics USD 247.9M 209.96M Sep/2025
Sartorius EUR 393.2M 23M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 67.63M 15.62M Mar/2025
Ultragenyx Pharmaceutical USD 131.94M 11.55M Sep/2025
United Therapeutics USD 602.1M 108.9M Sep/2025
Vertex Pharmaceuticals USD 2.66B 104.4M Sep/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025